جست‌وجوی استاد و پژوهشگر

Terence Wuerzمشاهده پروفایل

استادیار

• Antimicrobial Resistance
• Clinical Infectious Diseases
• Optimal Antimicrobial Use
• +۲ مورد دیگر

Dr. Terence Wuerz is an Assistant Professor at the University of Manitoba , affiliated with the Max Rady College of Medicine , where he works in the Department of Community Health Sciences and holds a cross-appointment in the Section of Infectious Diseases within the Department of Internal Medicine. Education : Doctor of Medicine (2007), University of Manitoba; Master of Sciences in Epidemiology (2018), University of London; Fellowships in Internal Medicine (2011, Dalhousie University) and Infectious Diseases (2012, University of Manitoba); Diploma in Tropical Medicine and Hygiene (2012), University of Alabama. His research focuses on clinical infectious diseases , antimicrobial resistance , and optimal antimicrobial use . Notably, he co-founded the Manitoba AMR Alliance in 2022, a web-based platform aimed at promoting antimicrobial stewardship through clinical tools and education. He leads national and international multi-site clinical trials investigating therapies for infections like S. aureus , C. difficile , and COVID-19 , emphasizing responsible antimicrobial prescribing to mitigate resistance and improve patient outcomes. Dr. Wuerz has extensive clinical experience as an internist in Yellowknife, Northwest Territories, before transitioning to academia. His work bridges epidemiology, public health, and clinical practice to enhance healthcare quality through evidence-based antimicrobial strategies and interprofessional collaboration.

• Critical Care Medicine
• Gastroenterology
• Hepatology
• +۷ مورد دیگر

Joanna Dionne is an Associate Professor in Medicine at McMaster University with a distinguished research career focused on critical care medicine, gastroenterology, and hepatology. Her work primarily addresses gastrointestinal complications in critically ill patients, with particular emphasis on stress ulcer prophylaxis, diarrhea management, and liver-related conditions in intensive care settings. Dr. Dionne's research interests span several key areas: Critical Care Medicine - particularly management of gastrointestinal complications in ICU patients Gastroenterology - with focus on diarrhea, Clostridioides difficile infection, and hepatic encephalopathy Hepatology - including liver transplantation and acute liver failure management End-of-life care in critical care settings Nutrition in critically ill patients Her scholarly work demonstrates a strong emphasis on systematic reviews, meta-analyses, and clinical practice guidelines, particularly in the areas of stress ulcer prophylaxis, gastrointestinal bleeding prevention, and management of liver conditions in critically ill patients. Dr. Dionne has been instrumental in developing guidelines for the Society of Critical Care Medicine and American Society of Health-System Pharmacists. Dr. Dionne has received significant recognition for her work, with numerous publications being blogged by multiple outlets, widely shared on social media platforms, and picked up by news outlets. Her research on the 3 Wishes Project highlights her commitment to humanistic aspects of critical care, focusing on spiritual care at the end of life. She maintains an active collaborative network with Deborah Cook, Bram Rochwerg, and Simon Oczkowski among her most frequent co-authors. Her work spans high-impact journals including Critical Care Medicine, Gastroenterology, Hepatology, and the New England Journal of Medicine.

• Respiratory Infections Diagnosis
• Gastrointestinal Infections Diagnosis
• Chronic Infections
• +۷ مورد دیگر

Marek Smieja is Professor of Pathology & Molecular Medicine at McMaster University's Faculty of Health Sciences. His extensive research program focuses on infectious disease diagnostics and pathogenesis, with particular expertise in respiratory and gastrointestinal infections. He maintains active research collaborations in Canada and Botswana, contributing to global health research initiatives. Dr. Smieja's primary research interests include the diagnosis of respiratory and gastrointestinal infections, the role of chronic infections in respiratory and cardiovascular disease, and the development of diagnostic tests for SARS-Coronavirus, influenza, and rhinovirus. His work bridges clinical medicine, microbiology, and diagnostic technology development. His HIV research examines the interaction between HIV infection and cardiovascular disease, with current studies focusing on smoking cessation, inflammation, and dental health. Analysis of his recent publications reveals a strong focus on respiratory virus epidemiology, diagnostic test development, microbiome research, and HIV-related cardiovascular complications. His work demonstrates consistent contributions to understanding infection dynamics, developing novel diagnostic approaches, and addressing health challenges in both Canadian and international settings. Dr. Smieja has established significant research collaborations with McMaster HealthLabs, Hamilton Health Sciences, and international partners in Botswana. His work on the Canadian Immunization Research Network (CIRN) study and involvement in the REPRIEVE trial demonstrate his engagement with major national and international research initiatives. His scholarly impact is substantial, with 156 publications in the last 10 years. His research program integrates laboratory science, clinical investigation, and public health approaches to address pressing infectious disease challenges. He has contributed to pandemic response efforts through studies on SARS-CoV-2 testing strategies and vaccine effectiveness.

• Molecular Microbiology
• Infectious Diseases
• Bacteriophages
• +۵ مورد دیگر

Colin Hill is a Professor of Microbiology at the School of Microbiology, University College Cork (UCC), Ireland. He leads research in bacteriophages, bacteriocins, and the microbiome's role in health and disease. He is a founding Principal Investigator at APC Microbiome Ireland, a multidisciplinary institute focusing on gut microbiota research. His work spans molecular mechanisms of infection, antimicrobial strategies, and translational microbiology. Affiliations: SFI Principal Investigator (since 2002), APC Microbiome Ireland PI, Past President of ISAPP (2012–2015). Education: Ph.D. in Molecular Microbiology. Research interests include developing bacteriophage-based therapies, bacteriocin engineering, and understanding microbiome interactions. His lab has produced over 600 peer-reviewed papers and 18 patents, with an H-index of 100 (ISI) and 135 (Google Scholar). Key achievements include the Metchnikoff Prize (2010) and election to the Royal Irish Academy and American Academy of Microbiology. His work on postbiotics and probiotics has shaped international consensus statements on fermented foods and microbial intake. Over 70 PhD students have graduated from his lab, and he has advised on grants and collaborations in APC Microbiome Ireland. Current projects focus on phage therapy, microbiome-based diagnostics, and interventions for Clostridioides difficile and inflammatory bowel disease.

Daniel Paredes Sabjaمشاهده پروفایل

دانشیار

• Microbiology
• Infectious Diseases
• Bacterial Pathogenesis
• +۳ مورد دیگر

Daniel Paredes-Sabja is an Associate Professor in the Department of Biology at Texas A&M University, affiliated with the College of Arts & Sciences. He joined the department in 2020 and leads the Paredes-Sabja Lab. His research focuses on bacterial pathogenesis, particularly Clostridioides difficile spore biology, toxin mechanisms, and infection recurrence. His work bridges microbiology, cell biology, and clinical applications. Education: Ph.D., Oregon State University (2009) Post-Doctoral training, Department of Biomedical Sciences, Oregon State University (2011) Food Engineering, Universidad Austral de Chile (2002) Research Interests: His lab investigates spore structure-function relationships, toxin-mediated pathogenesis, and host-microbe interactions. Key areas include spore adherence, germination mechanisms, and the role of sporobiota in antimicrobial resistance. Recent studies emphasize vaccine development targeting spore proteins and novel therapeutics against C. difficile infections. Publications Trends: Recent work highlights spore entry into intestinal epithelial cells, exosporium protein assembly, and toxin-induced redistribution of host receptors. Studies also address the role of Clp proteases and sporulation-associated genes in pathogenesis. Awards: No awards explicitly listed in provided texts. Advising & Grants: Advised at least one student (Paola Isabel Mora Uribe). Research supported by grants exploring spore biology and antibiotic alternatives. Collaborates with institutions like Universidad Andrés Bello (Chile) as a Visiting Professor. Labs/Teams: Directs the Paredes-Sabja Lab, focusing on Clostridium spp. pathogenesis and translational research. The lab employs microscopy, molecular biology, and animal models to study infection dynamics.

Katherine L. Knightمشاهده پروفایل

استاد

• Host-microbe interactions
• Immunology
• B cell biology
• +۷ مورد دیگر

Katherine L. Knight is a Professor in the Department of Microbiology and Immunology at Loyola University Chicago's School of Medicine. She leads a research laboratory focused on understanding how host-microbe interactions shape immune responses, particularly in the context of B cell biology and inflammatory diseases. Professor, Department of Microbiology and Immunology, Loyola University Chicago Ph.D., Indiana University Her research centers on the interplay between commensal microbes and the immune system, with a special focus on host-microbe interactions , trained immunity , and B cell development . The Knight Lab discovered that Bacillus subtilis , a harmless gut bacterium, is essential for B cell development and antibody diversity in rabbits. This bacterium, through its exopolysaccharide (EPS), induces anti-inflammatory macrophages and tolerogenic dendritic cells, thereby protecting against allergic asthma, graft-versus-host disease, autoimmunity, and Clostridium difficile infection. Her work on trained immunity explores how innate immune cells develop memory-like responses to microbial stimuli, offering novel avenues for therapeutic intervention. Her recent publications reveal a consistent focus on microbial immunomodulation, mucosal immunity, and the molecular mechanisms underlying inflammation and immune tolerance. Themes across her work include the role of the microbiome in immune education, the development of probiotic-based therapies, and the use of animal models—particularly rabbits—for studying human immune diseases. Discovery of Bacillus subtilis in B cell development Identification of exopolysaccharide (EPS) as an immunomodulatory molecule Development of mucosal vaccines against C. difficile using virus-like particles Elucidation of mechanisms in trained immunity Dr. Knight has mentored numerous researchers and maintains active collaborations, including with Dr. Qiao in her department on vaccine development. Her lab employs a range of techniques including gene knockout models, CRISPR, flow cytometry, and molecular biology to investigate immune pathways. She has not received any explicitly mentioned scientific awards in the provided text, but her sustained research output and leadership indicate significant recognition in the field. The Knight Lab continues to investigate the therapeutic potential of microbial molecules in preventing and treating inflammatory and autoimmune conditions, positioning her at the forefront of translational immunology.

• Artificial Intelligence
• Blockchain
• Healthcare Informatics
• +۴ مورد دیگر

Tsung-Ting Kuo is an Associate Professor in Biomedical Informatics & Data Science and Surgery at Yale School of Medicine. His primary appointment is in Biomedical Informatics & Data Science with a secondary role in Surgery. He holds adjunct affiliations with the Computational Biology and Biomedical Informatics program and the Yale Combined Program in the Biological and Biomedical Sciences (BBS). Education & Training PhD, National Taiwan University (2014), Institute of Networking and Multimedia Postdoctoral Scholar, University of California San Diego (2019) Research Focus Kuo's work centers on blockchain-based healthcare systems , distributed private modeling , and AI applications in biomedical data . He develops secure frameworks for cross-institutional data sharing, focusing on privacy preservation and robustness through decentralized technologies. Key areas include federated learning, clinical data interoperability, and genomic data security. Publications & Trends Recent work emphasizes privacy-preserving prediction models (e.g., C. difficile infection prediction) and blockchain solutions for consent management and research collaboration. His methods address challenges in equitable federated learning and model integrity across healthcare networks. Awards & Recognition NIH R01 Grant for blockchain-based healthcare research 2020 Faculty of the Year (UCSD) UCSD Chancellor’s Outstanding Postdoctoral Scholar Award Grants & Teams Active NIH funding supports projects in secure federated learning and blockchain applications. Collaborates with clinical teams at Yale New Haven Hospital and multi-institutional networks in California. Leads the Yale Biomedical Informatics & Computing (YBIC) initiative. Labs & Innovations Develops tools like WebQuorumChain (collaborative healthcare modeling framework) and ModelChain (decentralized predictive modeling system). Involved in Yale’s efforts to integrate blockchain into clinical research workflows.

• Microbiology
• Molecular Diagnostics
• Infectious Disease Diagnosis
• +۳ مورد دیگر

Kimberle C Chapin is a Professor of Medicine and Pathology and Laboratory Medicine at Brown University's Warren Alpert School of Medicine. She serves as Director of Microbiology for Lifespan Academic Medical Center. Her expertise spans Molecular Diagnostics , Clinical Pathology , and Infectious Disease management.

Rami Nakeshbandiمشاهده پروفایل

استادیار بالینی

• Antimicrobial stewardship
• Management of Clostridium Difficile Infection
• Hepatitis C Management

Rami Nakeshbandi, MD, is a Clinical Assistant Professor in the Department of Infectious Diseases at SUNY Downstate Health Sciences University. He serves as the ASP Director, focusing on antimicrobial stewardship and urban medicine complexities. Current affiliation: SUNY Downstate Health Sciences University Academic rank: Clinical Assistant Professor Department: Infectious Diseases Education Aleppo University School of Medicine, Aleppo/Syria Internal Medicine Residency: West Virginia University/Charleston Area Medical Center Infectious Diseases Fellowship: SUNY Downstate Health Sciences University Rami Nakeshbandi's research emphasizes antimicrobial stewardship , Clostridium Difficile infection management , and Hepatitis C treatment . His work addresses challenges in urban medicine and infectious disease control.

• Infectious Diseases
• Microbiology
• Pediatric Infectious Diseases
• +۶ مورد دیگر

Patricia Ferrieri is a Professor in Laboratory Medicine and Pathology and Pediatrics at the University of Minnesota . Her work spans clinical research, microbiology, and pediatric infectious diseases, with a focus on bacterial pathogenesis and infection control. Her research interests include Group B Streptococcus (GBS), Staphylococcus aureus decolonization, Borrelia miyamotoi neuroinfections, and microbial mechanisms in otitis media. She actively explores genomic epidemiology , diagnostic microbiology , and zoonotic pathogens . Publication trends show a consistent emphasis on bacterial genomics , infection control strategies , and emerging pathogens like Clostridioides difficile and Thelazia californiensis. Her recent work includes genome sequencing of Capnocytophaga, collaborative studies on preoperative S. aureus screening, and novel diagnostics for C. difficile. Grants and collaborations involve partnerships with the Bill & Melinda Gates Foundation , NIH , and Minnesota Department of Health . She led the Vikings Against Influenza project, targeting pediatric influenza prevention.

• Gastroenterology
• Hepatology
• Nutrition
• +۴ مورد دیگر

Kimberly C. Viskocil serves as an Associate Professor in the Department of Medicine at the University of Minnesota Medical School, specializing within the Gastroenterology, Hepatology, and Nutrition Division. Her academic role focuses on clinical research and patient care in gastrointestinal disorders with emphasis on microbiome-related pathologies. Dr. Viskocil's research centers on gut microbiome dynamics in disease contexts, particularly investigating Clostridium difficile infection mechanisms , fecal microbiota transplantation efficacy , and inflammatory bowel disease interactions . Her work bridges computational microbiome analysis with clinical gastroenterology, examining dysbiosis patterns and therapeutic interventions through rigorous statistical frameworks. Key contributions include developing detection methodologies for microbiome outliers and analyzing how immune-mediated conditions affect treatment outcomes. Analysis of her publication record (2014-2018) reveals a cohesive research trajectory focused on translational microbiome applications. Her work demonstrates strong interdisciplinary integration between bioinformatics, infectious disease modeling, and clinical gastroenterology, with particular emphasis on statistical validation of microbiome-based diagnostics and therapies. The high citation impact of her 2016 Clinical Gastroenterology and Hepatology paper (181 Scopus citations) underscores clinical relevance.

Brendan T. Wantaمشاهده پروفایل

پزشک-پژوهشگر

• Critical Care
• Anesthesiology
• Infection Control
• +۴ مورد دیگر

Brendan T. Wanta, MD is a Mayo Clinic physician scientist affiliated with the Department of Anesthesiology and Perioperative Medicine . His clinical focus spans critical care , liver transplantation , and infection control in surgical environments. Dr. Wanta completed his MD (2011) at Medical College of Wisconsin Critical Care Fellowship (2016) at Mayo School of Graduate Medical Education Anesthesiology Residency (2015) at Mayo Clinic with honors including the 2025 Distinguished Clinician Award and 2021 Catalyst Award . Research interests include UV-C disinfection technologies Operating room infection control Iron-sulfur cluster biogenesis with publications in journals like Cureus and J Cardiothorac Vasc Anesth . He actively contributes to resident education and curriculum development at Mayo Clinic. Scientific accolades include Alpha Omega Alpha Honor Society membership (2010) Foundation Fellowship in Government Service (2008) Michael J. Dunn Achievement Award (2011) alongside multiple clinician and educator of the year recognitions.

• Systems Biology
• Host-Microbiome Interactions
• Anaerobe Physiology
• +۴ مورد دیگر

Lynn Bry is a Professor of Pathology at Brigham and Women's Hospital , with affiliations to Harvard Medical School and the Massachusetts Host-Microbiome Center. She directs innovative research in host-microbiome interactions, metabolic modeling of anaerobes, and clinical pathogen surveillance. Education : Cornell University (BA), Washington University Medical School (MD/PhD) Leadership : Director of Massachusetts Host-Microbiome Center; Associate Medical Director of Clinical Microbiology services Her research focuses on Clostridioides difficile and gut microbiota , integrating systems biology , genomic surveillance , and gnotobiotic models to study infection prevention and microbiota's role in disease. Recent articles highlight work on redox metabolism, microbial urease inhibition, and the One Health approach to toxigenic Clostridia. Scientific awards include the 2021 Fellow of the American Academy of Microbiology, 2018 Research Leadership Award, and multiple mentoring accolades. She founded startups like iSpecimen and ParetoBio Inc., and teaches courses in anaerobe physiology and microbiome genomics. Clinical Role : Oversight of molecular testing for infectious agents and antimicrobial resistance programs Grants : NIH R01 awards for C. difficile redox metabolism (2023-2028), neurofilament biomarker research (2024), and host-gut microbiome interactions (2021-2026)

• Infectious Disease Epidemiology
• Antimicrobial Resistance
• Machine Learning in Healthcare
• +۵ مورد دیگر

Professor David Eyre at the University of Oxford is a leading researcher in infectious diseases with affiliations to: Infectious Disease Epidemiology Unit Modernising Medical Microbiology consortium Oxford NIHR Biomedical Research Centre NIHR Health Protection Research Unit His research focuses on: Preventing and treating infections through AI and big data Pathogen population genomics Dynamic time-to-event analysis for infection treatment Optimizing empirical antibiotic prescribing Machine learning for clinical diagnostics Culture-independent microbiology methods Recent work shows: Integration of whole-genome sequencing with clinical data Development of same-day diagnostic tools Mathematical modeling of disease transmission Application of network analysis to surveillance Bayesian approaches for pneumonia detection AMR epidemiology in immunocompromised patients Scientific recognition includes: Robertson Fellowship

Hanping Fengمشاهده پروفایل

استاد

• Immunology
• Cell Biology
• Infectious Diseases
• +۵ مورد دیگر

Dr. Hanping Feng is a Professor at the Department of Microbial Pathogenesis, University of Maryland School of Dentistry, with a secondary appointment as Associate Professor in the School of Medicine. His research focuses on host immune responses to infections, particularly Clostridium difficile pathogenesis, vaccine development, and immunotherapeutic strategies. Dr. Feng has led the creation of recombinant C. difficile toxins and animal models for studying chronic and recurrent infections. Yangtz River University (BAGR, 1993) Chinese Academy of Sciences (MS, 1996) University of Arizona (PhD, 2002) Dr. Feng's work spans immunology, cell biology, and infectious diseases. His lab has developed: Full-length C. difficile toxins A and B Animal models (piglet chronic CDI, mouse recurrent CDI) Ultrasensitive immunocytoxicity assays Chimeric dual-toxin vaccines and antitoxin antibodies His research also explores interactions between C. difficile toxins and host cells, including: Role of glucosyltransferase activity in pathogenesis Identification of cellular receptors for Toxin B Systemic dissemination of toxins and its link to disease severity